Analysis of the Risk Factors for the Neutropenic Fever in the High Risk NHL Patients for Developing Febrile Neutropenia Who Received 3-weekly CHOP-like Chemotherapy With Primary G-CSF Prophylaxis; Prospective Multicenter Observation Study

NCT01763398 · clinicaltrials.gov ↗
COMPLETED
Status
500
Enrollment
OTHER
Sponsor class

Conditions

Sponsor

Yonsei University

Collaborators